Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Pulmonary hypertension requires multidisciplinary approach for diagnosis, treatment
-
- Bystander-administered AEDs increase odds of survival in cardiac arrest
- CASA: Collaborative intervention improves fatigue, depression in HF
- DAPT superior to aspirin for outcomes after CABG
- Door-to-diuretic time not linked to clinical outcomes in acute HF
- Elevated BP increases risk for pregnancy loss in healthy women
- Exercise can decrease genetic risk for CVD
- Hip-hop program improves stroke literacy in children
- Immune checkpoint inhibitors may cause myocarditis
-
- Mortality, resource use in pediatric cardiac surgery vary by neighborhood income
- Obesity increases risk for CV mortality, shorter longevity
- Statin therapy prescribed less often in adult congenital heart disease
- Vegetable intake decreases risk for atherosclerosis in older women
- ANNEXA-4: Andexanet alfa halts anticoagulation in most patients with severe bleeding events
- CASABLANCA: Elevated endothelin-1 levels associated with CV events
- Closure may benefit patients with high-risk PFO
- Combination rivaroxaban, aspirin reduces major adverse limb events in PAD
-
- Continuous apixaban safe in patients undergoing catheter ablation for AF
- Dabigatran after noncardiac surgery reduces major CV complications in patients with myocardial injury
- DEFINE-FLAIR: iFR confers cost savings vs. FFR
- Sugary beverages increase mortality risk in older adults
- Best choice for antithrombotic therapy after TAVR depends on patient characteristics Daniel F. Miller, PharmD, BCPS; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
- Trial Scorecard: ANNEXA-4
- Trial Scorecard: CASABLANCA
- Trial Scorecard: CRYO4PERSISTENT AF
-
- Trial Scorecard: CVD-REAL 2
- Trial Scorecard: INTERMAP
- Trial Scorecard: NEXT
- Trial Scorecard: POISE
- Trial Scorecard: TRIUMPH